Amgen Reports Stronger-Than-Expected Profit Amid Lower Costs

Biotechnology giant Amgen has recently announced robust quarterly earnings that exceeded analysts' expectations, primarily driven by lower-than-anticipated production costs. The company's financial performance showcases its ability to navigate through challenging economic conditions while maintaining profitability.

Continue reading